Management of Morton's Neuroma
Begin with conservative management using ultrasound-guided corticosteroid plus local anesthetic injections, which provide superior outcomes compared to non-guided injections, followed by surgical neurectomy with nerve transposition or collagen conduit placement for refractory cases.
Initial Diagnostic Approach
Start with plain radiographs of the foot to exclude other causes of webspace pain such as osteoarthritis, Freiberg's infraction, and stress fractures, though radiographs are insensitive for diagnosing Morton's neuroma itself 1. When clinical suspicion is high after negative radiographs, proceed to either ultrasound or MRI for confirmation 1.
Imaging Performance
- MRI: Sensitivity 93%, specificity 68% for Morton's neuroma detection 1
- Ultrasound: Sensitivity 90%, specificity 88% - actually superior diagnostic capabilities compared to MRI in some meta-analyses 1
- Both modalities show comparable high sensitivities (83-96% for US, 82-96% for MRI) with no significant differences 1
Key advantage of ultrasound: Allows real-time clinical correlation during examination and can guide subsequent interventions 1.
Conservative Management Algorithm
First-Line: Ultrasound-Guided Corticosteroid Injection
Ultrasound-guided corticosteroid plus local anesthetic (UG CS+LA) is superior to non-guided injection and should be your initial intervention 2:
- Pain reduction: Mean difference of -15.01 mm on VAS compared to non-guided injection (moderate-certainty evidence) 2
- Improved function: Standardized mean difference of -0.47 favoring ultrasound guidance (moderate-certainty evidence) 2
- Higher satisfaction: 71% more likely to achieve patient satisfaction compared to non-guided injection 2
- Adverse events: Low rate (4.9%) including depigmentation or fat atrophy 2
Alternative Conservative Options
Corticosteroid injection alone versus local anesthetic: Shows little to no difference in pain or function at 3-6 months, though adverse events (skin atrophy, hypopigmentation, plantar fat pad atrophy) occur in approximately 10% of cases 2.
Other modalities with emerging evidence:
- Extracorporeal shock wave therapy (ESWT): Multiple sessions at one-week intervals without local anesthesia at maximum tolerable energy flux density may optimize outcomes. Local anesthesia may inhibit mechanotransduction and reduce success rates 3. However, current RCT evidence shows uncertain benefit (MD: -5.9,95% CI: -21.9 to 10.1) 4.
- Manipulation/mobilization: Moderate evidence for pain reduction (MD: -15.3 on VAS) 4
Percutaneous ultrasound-guided neurolysis with betamethasone: Recent evidence shows significant pain reduction (VAS from 7.1 to 1.1) in 86% of patients at 12 months, particularly effective for smaller neuromas (<250 mm³) 5.
Surgical Management
Indications for Surgery
Proceed to surgery when conservative management fails after 3-6 months, or when neuroma volume is large (>400 mm³ based on recurrence patterns) 5.
Surgical Technique Selection
For primary surgery: Neurectomy remains the gold standard, but the approach matters less than the technique - both plantar and dorsal incisions show similar outcomes 6. However, adding nerve transposition improves outcomes:
- Neurolysis with dorsal nerve transposition shows lower rates of postoperative neurogenic symptoms compared to simple neurectomy 7
- If neurectomy is performed, strongly recommend intramuscular embedding or intermuscular transposition of the nerve cutting end 7
For recurrent Morton's neuroma: Use collagen conduit placement with the nerve passed dorsally into the intermetatarsal space and secured to dorsal fascia:
- 85% patient satisfaction rate 6
- Mean VAS pain reduction from 8-10 preoperatively to 0-4 postoperatively 6
- Avoids morbidity of deep soft-tissue dissection required for nerve burial 6
Surgical Approaches to Avoid
Minimally invasive deep transverse intermetatarsal ligament release: Effectiveness remains inconclusive - exercise caution 7.
Metatarsal shortening osteotomy: Insufficient evidence for routine use 7.
Critical Pitfalls to Avoid
Do not perform non-guided corticosteroid injections when ultrasound guidance is available - you sacrifice 15 points on VAS and significantly reduce patient satisfaction 2
Do not use local anesthesia with ESWT if pursuing this modality - it may inhibit the mechanotransduction necessary for therapeutic effect 3
Do not perform simple neurectomy without nerve transposition or burial - this increases risk of recurrent neurogenic symptoms 7
Do not ignore neuroma size on imaging - neuromas >400 mm³ have higher recurrence rates with conservative management and may warrant earlier surgical intervention 5
Rule out alternative diagnoses before treatment: intermetatarsal bursitis, plantar plate tears, Freiberg's infraction, and stress fractures can mimic Morton's neuroma 1
Postoperative Protocol (for surgical cases)
- Non-weight-bearing for 2 weeks
- Partial weight-bearing with boot and physical therapy initiation at 2 weeks
- Gabapentin 300 mg tapered by 6 weeks
- Follow-up at 2,6,12,24, and 52 weeks monitoring for infection and recurrence 6